Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrator complex subunit 12 (INTS12) is a highly conserved nuclear protein and an essential component of the integrator complex, a multi-subunit assembly that associates with RNA polymerase II to mediate the 3′ end processing of small nuclear RNAs (snRNAs). INTS12 contains a PHD finger domain, which is typical for proteins involved in chromatin-dependent transcriptional regulation, but its key functional domain for integrator activity is a small N-terminal microdomain responsible for protein-protein interactions and stabilization of other integrator subunits. In addition to its canonical role in snRNA maturation, INTS12 binds throughout the genome at transcriptionally active sites and regulates expression of genes involved in protein synthesis, cell translation, and chromatin architecture. Recent studies implicate INTS12 in the maintenance of HIV latency, as knockdown of INTS12 in HIV-infected cells leads to activation of viral transcription and enhances the effect of latency-reversing agents, without causing overt cell toxicity. Genetic variations in the INTS12 gene locus have been associated with alterations in lung function and the risk for chronic obstructive pulmonary disease (COPD). Overall, INTS12 functions as both a transcriptional regulator and a core processing factor for RNA maturation, with emerging significance in human disease mechanisms including HIV infection and pulmonary function.
Synergistic latency reactivation by removal of transcriptional silencing in HIV; Enhancement of HIV transcription by combinatorial knockdown with latency-reversing agents; Null (no classic agonist, antagonist, inhibitor mechanism described)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrator complex subunit 12 (INTS12).